In Brief
The role of host-derived intestinal metabolites in mucosal immune regulation is poorly understood. Here, Cao et al. show that effector CD4 + T cells upregulate expression of the xenobiotic transporter, Mdr1, in the ileum to safeguard immune homeostasis, revealing an important immunologic consequence of ileal bile acid reabsorption.
SUMMARY

CD4
+ T cells are tightly regulated by microbiota in the intestine, but whether intestinal T cells interface with host-derived metabolites is less clear. Here, we show that CD4 + T effector (Teff) cells upregulated the xenobiotic transporter, Mdr1, in the ileum to maintain homeostasis in the presence of bile acids. Whereas wild-type Teff cells upregulated Mdr1 in the ileum, those lacking Mdr1 displayed mucosal dysfunction and induced Crohn's disease-like ileitis following transfer into Rag1 À/À hosts. Mdr1 mitigated oxidative stress and enforced homeostasis in Teff cells exposed to conjugated bile acids (CBAs), a class of liver-derived emulsifying agents that actively circulate through the ileal mucosa. Blocking ileal CBA reabsorption in transferred Rag1 À/À mice restored Mdr1-deficient Teff cell homeostasis and attenuated ileitis. Further, a subset of ileal Crohn's disease patients displayed MDR1 loss of function. Together, these results suggest that coordinated interaction between mucosal Teff cells and CBAs in the ileum regulate intestinal immune homeostasis.
INTRODUCTION
Adaptive immunity requires naive CD4
+ T helper (Th) cell differentiation into cytokine-secreting effector (Teff) subsets (Nakayamada et al., 2012) . Teff cells, which include interferongamma (IFNg)-producing Th1 cells and interleukin-17 (IL-17)-secreting Th17 cells, downregulate lymphoid-homing receptors and upregulate tissue-homing chemokine receptors and integrins to egress lymphoid organs and infiltrate non-lymphoid tissues. However, the presence of Teff cells in non-lymphoid tissues is potentially deleterious, and elevated Teff cell cytokine expression in tissues is both a hallmark and an important therapeutic target in many inflammatory disorders, including inflammatory bowel diseases (IBDs) (Kaser et al., 2010) .
Intestinal microbiota play key roles in suppressing pro-inflammatory Teff cell function in the gut. For example, commensal microbes prevent trafficking of mucosal phagocytes to mesenteric lymph nodes to limit T cell priming (Diehl et al., 2013) , produce short-chain fatty acids or polysaccharide A to stimulate peripheral forkhead box P3 (Foxp3) + T regulatory (pTreg) cell development or IL-10 expression, respectively (Arpaia et al., 2013; Mazmanian et al., 2008) , and convert intestinal pTregs into CD4 + CD8aa + intraepithelial lymphocytes (IELs) (Sujino et al., 2016) . Still other enteric species, such as segmented filamentous bacteria, induce pro-inflammatory Th17 cell function in the gut (Atarashi et al., 2015; Sano et al., 2015) . Thus, major (B) Top, spleen T H cell subsets in C57BL/6 (B6) wild-type or Mdr1-reporter (Abcb1a AME/+ translational initiatives have been launched to characterize the human microbiome in human health and disease and to test microbiota-directed therapies in IBDs. Far less is known about host-derived intestinal metabolites in mucosal immune regulation. Like the microbiota, bile acids (BAs) constitute a unique and fundamental aspect of gastrointestinal physiology (Hofmann and Hagey, 2014) . BAs are detergent-like metabolites that are synthesized in the liver, stored in the gall bladder, and secreted into the proximal small intestine (i.e., duodenum) upon food intake. BAs emulsify dietary lipids in the small intestinal lumen and are reabsorbed in the distal small intestine (i.e., ileum) by epithelial cells expressing the apical sodium-dependent BA transporter, Asbt (Dawson et al., 2003) . Reabsorbed BAs accumulate in the lamina propria and enter portal circulation for return to the liver (Hofmann and Hagey, 2014) . Still, immunologic consequences of BA reabsorption in the ileum remain unknown.
MDR1 (ABCB1) is a membrane-associated, ATP-dependent efflux pump recognized for transporting chemotherapeutic drugs out of tumor cells (Gottesman et al., 2002) . We previously reported that MDR1 is preferentially expressed in intestinal versus circulating human Teff cells (Ramesh et al., 2014) . Intriguingly, mice lacking Abcb1a-the mouse ortholog of human ABCB1-are prone to spontaneous colitis (Panwala et al., 1998) , and ABCB1 polymorphisms have been associated with human IBDs (Annese et al., 2006) . However, MDR1 remains widely considered a dedicated ''drug handler'' in mammals (Borst and Schinkel, 2013) .
Here, we determined that Mdr1 was also expressed in mouse Teff cells at steady state, where it was increased in the small intestine lamina propria, highest in the ileum, and induced by CD103 + dendritic cells (DCs). Consistent with these findings,
Teff cells lacking Mdr1 displayed mucosal dysfunction in the ileum and transferred Crohn's disease-like ileitis in Rag1
À/À hosts. Mdr1 acted during BA exposure to limit oxidative stress and enforce Teff cell homeostasis, and blocking ileal BA reabsorption in transferred Rag1 À/À mice restored Mdr1-deficient
Teff cell homeostasis and attenuated ileitis. Further, a subset of ileal Crohn's disease patients displayed MDR1 loss of function. Together, these data suggest that circulating Teff cells upregulate Mdr1 in the ileum to compensate for BA reabsorption and safeguard intestinal homeostasis.
RESULTS
Effector CD4 + T Cells Upregulate Mdr1 Expression in the Ileum
Considering that physiologic MDR1 functions will involve interaction with unknown metabolites, we investigated the function of Mdr1 in T cells using in vivo mouse models rather than in vitro human cell culture. Using efflux of the fluorescent Mdr1 substrate, rhodamine 123 (Rh123) (Ludescher et al., 1992) , we first confirmed that Mdr1 was expressed in a portion of endogenous mouse Teff cells at steady state ( Figure 1A ). Teff cell Rh123 efflux was due to Mdr1, as (1) Rh123 efflux was abolished by ex vivo treatment with the Mdr1 antagonist, elacridar (Hyafil et al., 1993) ; (2) Rh123 efflux was absent in Teff cells from Mdr1-deficient mice (FVB.Abcb1a
; abbreviated hereafter as FVB.Abcb1a/1b À/À ) (Schinkel et al., 1997) ; and (3) wild-type Teff cells isolated by fluorescence-activated cell sorting (FACS) based on Rh123 efflux displayed enrichment for Abcb1a expression, but not other multidrug transporter messenger (m)RNAs (e.g., Abcc1, Abcc3, Abcg2) (Figures 1A, S1A, and S1B). As in humans (Ramesh et al., 2014) , Rh123 efflux was absent in mouse naive T cells and higher in Teff cells versus Tregs (Figures 1A and S1A) . Within Teff cells, Rh123 efflux was evident in both Th17 and non-Th17 (mostly IFNgexpressing Th1) cells, as determined in studies using Th17 fate-mapping reporter (Il17a
Cre R26 ) mice (Figures S1C-S1F), where Cre recombinase-induced human CD2 expression stably marks Teff cells that have expressed Il17a during development. However useful, Rh123 is an indirect measure of Mdr1 expression that requires ex vivo manipulation, and no commercial antibodies permit direct detection of mouse Mdr1 by flow cytometry. Therefore, we generated a fluorescent Mdr1-reporter mouse (Abcb1a AME/+ ) using CRISPR/Cas9 gene editing in wild-type C57BL/6 (B6) zygotes (Yang et al., 2013) . We replaced the Abcb1a stop codon with a bi-cistronic reporter cassette containing a P2A peptide sequence and the fluorescent transgene, ametrine ( Figures S2A and S2B ). Although an in-frame 9-nucleotide (3-amino acid) deletion was found near the 3 0 end of the targeted Abcb1a allele ( Figures S2C and S2D ), Rh123 efflux remained intact in Abcb1a AME/+ T cells ( Figure S2E ). Ametrine mean fluorescence intensity (MFI) (Figures 1C and 1D ; data not shown). Increased Mdr1 expression in siLP Teff cells was evident by Rh123 efflux on several wild-type backgrounds (e.g., C57BL/6, FVB, BALB/c) ( Figure 1C ; data not shown) and in transferred Rag1 À/À mice receiving wild-type or Abcb1a AME/+ naive T cells ( Figure 1E ). Within siLP, Mdr1 expression increased in Teff cells in a gradient fashion from proximal to distal, with highest expression occurring in the ileum ( Figure 1F ). Figure S3C ). Whereas intestinal CD11c + DCs that induced Teff cell Mdr1 expression in vitro were heterogeneous for CD103 and chemokine CX3C motif receptor 1 (CX 3 CR1) expression ( Figure 1G ), only purified CD103 + DCs induced
Mdr1 expression in co-cultured Teff cells ( Figure 1G ). Finally, Mdr1 expression in siLP Teff cells was independent of microbiota, as high-level Rh123 efflux was observed in siLP Teff cells from germ-free (GF) mice ( Figure S3D ). Accordingly, intestinal DCs from both specific pathogen-free (SPF) and GF mice induced Mdr1 expression in co-cultured Teff cells ( Figure S3E ). Thus, circulating Teff cells upregulate Mdr1 expression upon migration into the ileal mucosa and do so irrespective of microbiota.
Mdr1 Regulates Effector T Cell Function in the Ileum
Mdr1-deficient T cells induced more aggressive weight loss than wild-type counterparts upon transfer into FVB.Rag1 À/À mice ( Figure 2A ). Inflammation in this model is generally restricted to the colon (Powrie et al., 1994) , and both wild-type and Mdr1-deficient T cells induced severe colitis (Figures 2B and 2C) . However, Mdr1-deficient T cells also induced ileitis, whereas wild-type cells did not (Figures 2B and 2C) . Mucosal inflammation in transferred Rag1 À/À mice requires antigens from the enteric flora (Jones-Hall and Grisham, 2014) . However, non-microbial factors contributed to the propagation of Mdr1-deficient T cell-driven ileitis. First, Rag1 À/À mice used in these studies were co-housed, indicating that Mdr1-deficient T cell-induced ileitis was not transmissible through coprophagia. Second, ileitis in this model was not associated with dysbiosis, as judged by 16S ribosomal DNA sequencing ( Figures S4A-S4C ). Third, Rag1 À/À mice receiving Mdr1-deficient T cells displayed increased weight loss and ileitis compared with wild-type T cell recipients, even after broad-spectrum antibiotic therapy ( Figures 2D-2F and S4D ). In addition, ileitis in this model was not indirectly due to aberrant T cell development or function in FVB.Abcb1a1b À/À mice, as short hairpin (sh)RNA-mediated depletion of Abcb1a and Abcb1b (shMdr1) in wild-type T cells ( Figure S5A ) also increased T cell-driven weight loss and ileitis in Rag1 À/À mice, compared with a control shRNA against 
Conjugated Bile Acids Modulate Mdr1 Function
In vitro incubation of wild-type splenic Teff cells with sterile, soluble luminal content (LC) from small intestine (siLC), but not colon (cLC), inhibited Rh123 efflux ( Figure 4A ), suggesting that components within siLC modulate Mdr1 function. Given both the high-level Mdr1 expression in mucosal Teff cells from GF mice ( Figure S3D ) and the persistent ileitis in antibiotic-treated Rag1 À/À mice receiving Mdr1-deficient T cells, we hypothesized that Mdr1 interfaces primarily with host-derived metabolites. As noted above, BAs are restricted to the small intestine due to active reabsorption in the ileum (Hofmann and Hagey, 2014) . BAs are also cytotoxic to cells at high concentrations, as in cholestatic liver diseases where BA accumulation induces hepatocellular necrosis (Poupon et al., 2000) . Indeed, siLC, but not cLC, from wild-type mice was cytotoxic to cultured T cells (data not shown). Two results confirmed that BAs are the principal Mdr1-modulating metabolites within siLC. First, BA concentrations were equivalent in siLC from GF and SPF mice ( Figure S6A ), and both inhibited Rh123 efflux ( Figure S6B ). Second, depleting BAs from either GF or SPF siLC with the BA sequestering resin, cholestyramine (Arnold et al., 2014) , abolished siLC-mediated inhibition of Rh123 efflux (Figures 4A and S6B) . In line with these results, siLC BA concentrations in transferred Rag1 À/À mice were not affected by antibiotic therapy ( Figure S6C ), and siLC from both control and antibiotic-treated Rag1 À/À mice inhibited Rh123 efflux ( Figures S6D and S6E ).
Five major BA species are present in mammals: cholic acid (CA), chenodeoxycholic acid (CDCA), and b-muricholic acid (bMCA) are primary BAs synthesized by hepatocytes in the liver, whereas deoxycholic acid (DCA) and lithocholic acid (LCA) are secondary BAs that derive from enzymatic actions of microbiota on primary BAs (Hofmann and Hagey, 2014) . Each BA species can exist in a free/un-conjugated form or as conjugated to the amino acids taurine or glycine (Hofmann and Hagey, 2014) . However, the majority of intestinal BAs in vivo are membrane-impermeant conjugated BAs, maintained by enterohepatic circulation through the ileum (Hofmann and Hagey, 2014) . Each BA species was cytotoxic to wild-type T cells in vitro at or above their critical micelle concentration ($2.5-10 mM), and each inhibited Mdr1-dependent Rh123 efflux in a dose-dependent manner at lower concentrations (0.5-2 mM) ( Figures 4B and S6F ). However, only glycine-or taurine-conjugated BAs (CBAs) inhibited Rh123 efflux (Figures 4B and S6F) . Further, both mouse siLC and commercially synthesized CBAs also inhibited Rh123 efflux mediated by human MDR1 ( Figure S6G ). Thus, the specific interplay between Mdr1 and CBAs predicts our observations above that phenotypes of Mdr1-deficient Teff cells in vivo are amplified at the site of CBA reabsorption, the ileum.
Mdr1 Enforces T Cell Homeostasis in the Presence of Conjugated Bile Acids
To assess direct impacts of Mdr1 and CBAs on Teff cell function, we cultured splenocytes from wild-type or Mdr1 null mice in the presence or absence of synthetic CBAs. After a 4 hr incubation period, we stimulated these cells and analyzed TNF (Dawson et al., 2003) . Therefore, we tested if Asbt-dependent CBA reabsorption promotes mucosal dysfunction of Mdr1-deficient siLP Teff cells in vivo. We crossed B6.Asbt-deficient (Slc10a2 À/À ) mice with B6.Rag1 À/À mice and then injected these mice with congenic mixtures of un-transduced, shCD8-expressing, or shMdr1-expressing B6 T cells ( Figure 4E Figure 4G , bottom). These transcripts were (1) regulated selectively in siLP versus spleen; (2) reduced, as a rule, in Mdr1-deficient siLP Teff cells by Asbt ablation; and (3) enriched for genes whose encoded proteins are involved in the oxidative stress response, DNA damage and nucleotide excision repair, apoptosis and p53 signaling, and nuclear factor kB (NF-kB) signaling (Figures 4G and 4H) . Given that oxidative stress involves lipid peroxidation and the generation of highly reactive lipid aldehydes (e.g., malondialdehyde, 4-hydroxy-2-nonenal, etc.) (Ayala et al., 2014) , which damage cells by forming adducts with proteins and genomic DNA and lead to activation of DNA repair and p53 and NF-kB pathways (Ayala et al., 2014; Kabe et al., 2005) , these data suggest that Mdr1 protects Teff cells from CBA-driven oxidative stress in the ileum. Consistent with a mechanism involving oxidative stress, Mdr1 was also important for Teff cell survival in the presence of CBAs. First, Mdr1 depletion by shRNAs led to systemic defects in Teff cell persistence in transferred Rag1 À/À mice (Figures 5A and 5B; data not shown), which is consistent with the extensive circulation of Teff cells in and out of the gut (Morton et al., 2014) . Second, the same concentration of tCDCA (1.2 mM) that drove TNF overexpression in cultured Mdr1-deficient versus wildtype Teff cells after 8 hr ( Figures 4C and 4D ) killed 80%-90% of wild-type T cells after 24 hr ( Figure 5C ); those that survived were uniformly Mdr1 + Teff cells, whether judged by Rh123 efflux in wild-type cells ( Figure 5C ) or ametrine expression in Abcb1a AME/+ reporter cells ( Figure 5D ). Third, neither elacridartreated wild-type T cells nor Mdr1 null T cells survived overnight culture with tCDCA ( Figures 5E and 5F ). Finally, ectopic expression of hMDR1, but not the transport-deficient mutant, promoted durable survival of EL4 cells in the face of chronic tCDCA treatment (Figures S7F and S7G) . Thus, the initial pro-inflammatory (E) Un-transduced, shCD8-expressing, or shMdr1-expressing B6 wild-type T cells were mixed and transferred into co-housed Asbt-sufficient or Asbt-deficient B6.Rag1 À/À mice. Cells were re-isolated from siLP and analyzed 6 weeks post transfer. Representative of 6 mice over 2 experiments.
(F) Mean percentages (±SEM; n = 6) of TNF + shCD8-or shMdr1-expressing siLP Teff cells from transferred and co-housed Asbt (A) Un-transduced, shCD8-expressing, or shMdr1-expressing FVB wild-type T cells were mixed and transferred into FVB.Rag1 À/À mice (as in Figure 3E ). response of Mdr1-deficient Teff cells to CBA-driven oxidative stress is cytotoxic over time.
Increased concentrations of reactive oxygen species (ROS) were also evident by flow cytometry in tCDCA-treated Mdr1-deficient Teff cells (Figures 5G and 5H ). By contrast, ROS concentrations were similarly low in untreated wild-type and Mdr1-deficient Teff cells and strongly induced in both genotypes by hydrogen peroxide (H 2 O 2 ) ( Figure 5G ). Accordingly, the small-molecule anti-oxidant, N-acetyl-L-cysteine (N-Ac), decreased ROS concentrations in tCDCA-treated Mdr1-deficient Teff cells and restored their survival to wildtype levels ( Figures 5I and 5J ). Teff cells lacking Mdr1 also displayed increased ROS concentrations and decreased survival in the presence of 13-hydroperoxy-octadecadienoic acid (13-HpODE), an oxidized lipid derived from lineoleic acid, but not in the presence of mitochondrial destabilizers (e.g., H 2 O 2 and menadione) (Figures S7H-S7K) (Schneider et al., 2001; Thorpe et al., 2004; Gerasimenko et al., 2002) . Thus, these results suggest that CBAs induce, and Mdr1 mitigates, lipid peroxidation.
Bile Acid Sequestration Restores Mdr1-Deficient Effector T Cell Homeostasis BA sequestrants, which bind CBAs in the intestinal lumen and prevent their reabsorption into the ileal lamina propria (Arnold et al., 2014) , could be pharmacologically useful to restore mucosal homeostasis in Mdr1-deficient Teff cells. To test this, we administered cholestyramine (CME) to FVB.Rag1 À/À mice receiving wild-type or Mdr1-deficient T cells. CME-fed Rag1 À/À mice displayed increased fecal BA excretion ( Figure 6A ), which was similar to Asbt-deficient mice and indicative of reduced ileal CBA reabsorption (Dawson et al., 2003) . Further, CME treatment reduced both weight loss and ileitis in Rag1 À/À mice receiving Mdr1-deficient T cells, without influencing either the normal small bowel histology in Rag1 À/À mice receiving wild-type T cells or the severe colitis present in both groups of Rag1
Consistent with these therapeutic effects and similar to Asbt ablation ( Figures 4E and 4F ), CME treatment reduced both TNF production and oxidative stress-related gene expression in Mdr1-deficient, but not wild-type, siLP Teff cells ( Figures  6E-6H ). By contrast, CME had no influence on cytokine production or gene expression in either wild-type or Mdr1-deficient Teff cells outside of the small intestine (Figures 6E-6H ; data not shown). Although BA sequestration alters liver metabolism (Bhat et al., 2003) , both the selective regulation of Mdr1-deficient siLP Teff cell function and the similar pharmacodynamic effects of CME treatment and Asbt ablation suggest that CME acts locally in this model to prevent the pathogenic interaction between Mdr1-deficient Teff cells and CBAs in the ileum.
MDR1 Loss of Function in a Subset of Human Crohn's Disease Patients
These results in mice suggest that MDR1 function may be impaired in some patients with ileal Crohn's disease (CD). Whereas loss-of-function mutations in the human MDR1 gene, ABCB1, are rare and not generally associated with human IBDs (Jostins et al., 2012) , we reasoned that identifying even a handful of MDR1-deficient ileal CD patients might inform both mechanistic understanding and personalized therapy. Therefore, we profiled MDR1-dependent Rh123 efflux in peripheral blood T cells from 183 healthy adults and IBD patients (Table S1 ). We determined the combined frequency of Rh123 lo cells within four major MDR1-expressing CD4 + and CD8 + T cell subsets ( Figures 7A and 7B ), and we ensured assay reliability over time by analyzing Rh123 efflux in a control stock of healthy donor peripheral blood mononuclear cells (PBMCs) in parallel with each batch of samples ( Figure 7C ). While robust, this measure of ''absolute'' MDR1 function placed unequal weight on the four T cell subsets, with CD4 + Teff cells accounting for %10% of total MDR1 activity in most individuals ( Figure 7B ). Therefore, to more accurately reflect germline-encoded MDR1 function, we established a rank-order scoring system that assigns a normalized value between 1 (lowest) and 183 (highest) for MDR1 function within each T cell subset; the sum of these values, or ''rank-order'' MDR1 function, lends equal weight (25%) to MDR1 function within each subset. Whereas absolute and rank-order MDR1 function strongly correlated within individuals (r = 0.975, p < 0.0001), rank-order scoring reduced the ''false discovery'' of patients where MDR1 function was compromised in some, but not all, T cell subsets ( Figure 7D ). We confirmed that rank-order MDR1 function was normally distributed within all control and patient groups ( Figure 7E ) and not generically influenced by bowel surgeries or medications (Figures 7F and 7G) .
We found that MDR1 function was reduced, on aggregate, in all IBD patient groups relative to healthy controls but was not different between discrete forms of IBD ( Figure 7H ). This result may reflect a general loss of mucosal homeostasis in all IBDs that impacts MDR1 regulation in the gut. At the same time, we identified 8 IBD patients (5 ileal CD, 3 UC) that displayed overt MDR1 loss of function below a maximum specificity threshold for IBD patients defined by receiver operating characteristic (ROC) analysis ( Figure 7H ). The area under curve (AUC) in ROC analysis was 0.72 with a confidence interval of 0.63-0.80, which was significantly different from 0.5 (p < 0.0001), indicating that rank-order MDR1 function could discriminate IBD patients from controls ( Figure 7H ). Therefore, we used a 100% specificity threshold for IBD patients (sensitivity = 6.4%; rank-order MDR1 function % 94.5) to identify MDR1 ''low-outliers'' ( Figure 7H ). MDR1 low-outliers showed impaired Rh123 efflux in all four Burzyn et al., 2013; Cipolletta et al., 2012; Schiering et al., 2014) . Thus, adaptation in non-lymphoid tissues may be a general feature of circulating lymphocytes. Our study reveals that BAs play a key role in shaping Teff cell function in the ileum. Due to their primary roles in digestion, CBAs are synthesized in the liver and reabsorbed in the ileum in manners that are influenced by, but not strictly dependent on, microbiota (Hofmann and Hagey, 2014) . Accordingly, Mdr1 was highly expressed in intestinal Teff cells from GF mice and required for mucosal Teff cell homeostasis in transferred Rag1 À/À mice treated with antibiotics. Still, BAs are known to shape the enteric flora due to bactericidal and bacteriostatic activities (Lorenzo-Zú ñ iga et al., 2003), and microbiota directly alter luminal BAs through enzymatic activities (Albenberg et al., 2012) . Therefore, our results reveal a third dimension in the interplay between BAs, the microbiota, and the mucosal immune system.
The size and composition of the mucosa-associated CBA pool in the ileum remains ill-defined. Current estimates consider CBAs in the ileal lamina propria at high micromolar concentrations, between those documented in the ileal lumen (1-10 mM) and portal vein ($50 mM) (Hofmann and Hagey, 2014) . In line with these estimates, synthetic CBAs (e.g., tCDCA) modulated Mdr1 function and Teff cell homeostasis between 250-1,200 mM, and endogenous BAs from the intestinal lumen interacted with Mdr1 at even lower concentrations (25-100 mM). In vitro tCDCA treatment recapitulated several aspects of Mdr1-deficient Teff cell mucosal dysfunction in vivo, including oxidative stress, TNF overexpression, and decreased persistence. Nevertheless, understanding the full scope of mucosal Teff-CBA interactions in vivo will require new insights into the endogenous CBA pool, the duration of Teff cell persistence in the ileum, and how these parameters change during disease, dysbiosis, and dietary alteration.
Our results indicate that Mdr1 mitigates CBA-driven oxidative stress in Teff cells. This notion is supported by previous reports showing that CBAs kill transformed epithelial cells through oxidative stress (Ignacio Barrasa et al., 2011) and that Mdr1 protects against oxidative stress in intestinal epithelial cells (Ho et al., 2017) . The only endogenous Mdr1 transport substrates described to date are short-chain phospholipids (van Helvoort et al., 1996) , and these are generated during lipid peroxidation (Ayala et al., 2014) . Thus, these data support a model in which Mdr1 limits CBA-driven lipid peroxidation by removing oxidized lipids from the T cell plasma membrane. This model predicts a fundamental role for Mdr1 in cellular protection from lipid peroxidation, which is consistent with both the broad expression of MDR1 in mammalian cells and the evolutionary conservation of MDR1 orthologs in prokaryotes. Indeed, Mdr1 also suppressed oxidative stress in Teff cells exposed to 13-HpODE-an oxidized derivative of linoleic acid-but had little impact on stress induced by other ROS. A less likely possibility is that Teff cells internalize, and Mdr1 directly effluxes, CBAs.
Whatever the case, mucosal homeostasis coordinated by MDR1 and CBAs appears to be critical for immune homeostasis in the ileum and may be compromised in a subset of ileal CD. We identified 5 MDR1 lo patients with aggressive ileal CD that included 2 males and 3 females, spanned three ethnic backgrounds, and ranged in age between 27 and 60. Whether MDR1 loss of function in these patients is due to genetic perturbation is not yet clear, though the breadth and magnitude of MDR1 deficiency in these patients is consistent with underlying genetic mutations. Given our data in mice, it will be important to determine whether BA sequestration is an effective therapy for MDR1 lo CD patients. Whereas BA sequestrants have yet to be formally tested in CD, a recent study found that CME induced mucosal healing in a small cohort of IBD patients with primary sclerosing cholangitis (Pavlidis et al., 2015) . Our data suggest a mechanistic basis for this clinical result and encourage expanded efforts to test BA sequestrants in human CD.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents should be directed to and will be fulfilled by the Lead Contact, Mark Sundrud (msundrud@scripps.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
Wild-type C57BL/6 (B6; stock no. 000664), B6.Rag1 À/À (stock no. 002216) and B6.Il17a
Cre (stock no. 016879) mice were purchased from The Jackson Laboratory. Wild-type FVB/N (model no. FVB) and FVB.Abcb1a
; model no. 1487) mice were purchased from Taconic. BALB/c mice were purchased from CLEA (Japan) and maintained under specific pathogen-free (SPF) or germ-free (GF) conditions at Osaka University. ROSA26
LSL-hCD2 transgenic mice were provided by Dr. Klaus Rajewsky (Max Delbruck Center for Molecular Medicine, Berlin, Germany 
In vitro experiments used T cells isolated from 8-to 14-week old male and female mice. T cell transfer colitis experiments used 6-to 10-week old female donor mice, and 8-to 12-week old syngeneic female recipients. This study was approved by Institutional Animal Care and Use Committees at The Scripps Research Institute (TSRI) Florida, Osaka University, and NYU Medical Center.
Human blood samples
Human blood samples were collected and analyzed in accordance with protocols approved by Institutional Review Boards at TSRI, OneBlood (Orlando, Florida), The University of Miami, and The University of California Los Angeles (UCLA). Blood was obtained after informed written consent, and consenting volunteers willingly shared clinical history and demographic data prior to phlebotomy. Institutional Review Boards at OneBlood, The University of Miami, and UCLA approved all procedures and forms used in obtaining informed consent, and all documentation for consenting volunteers is stored at OneBlood, The University of Miami or UCLA. Cryopreserved PBMC samples were stored in de-identified vials, and shipped to TSRI Florida for analyses.
Cell lines EL4 cells are a mouse thymic lymphoma cell line, and were obtained from Dr. Jun-Li Luo (TSRI Florida). Human platinum-E (PLAT-E) cells are derived from the HEK293 human embryonic kidney fibroblasts and engineered for improved retroviral packaging efficiency. NIH 3T3 cells are a mouse embryonic fibroblast cell line. PLAT-E and NIH 3T3 cells used for this study were provided by Dr. Matthew Pipkin (TSRI Florida). All cell lines were tested to be mycoplasma free, and cultured in DMEM plus 10% FBS, 2 mM L-glutamine, 50 uM 2-mercaptoethanol, 1% HEPES, and 100 U/mL Pen-Strep. We are not aware of any reports that disclose the gender of origin for EL4, PLAT-E, or NIH 3T3 cells.
Primary cell cultures
Single-cell suspensions of splenocytes magnetically purified CD4 + T cells from wild-type or T cell-transferred Rag1 À/À mice, were cultured in DMEM plus 10% fetal bovine serum (BioFluid Technologies), 2mM L-glutamine, 50uM 2-mercaptoethanol, 1% MEM vitamin solution, 1% MEM non-essential amino acids solution, 1% Sodium Pyruvate, 1% Arg/Asp/Folic acid, 1% HEPES and 100u/ml Pen-Strep.
METHOD DETAILS
Generation of Mdr1-Reporter (Abcb1a ametrine ) Mice Mdr1-reporter (Abcb1a ametrine ) mice were generated using the Cas9-cleavase system in wild-type C57BL/6 zygotes. Briefly, two guide RNAs (gRNAs) were identified using a publically available CRISPR design tool (http://crispr.mit.edu), which are predicted to introduce single-stranded nicks on opposite DNA strands 22 bp upstream and 10 bp downstream of the Abcb1a stop codon; synthetic gRNAs were purchased (PNA Bio) and Cas9-dependent cleavage at the Abcb1a locus was confirmed in vitro prior to zygote microinjection. The sequences of the gRNAs used in this targeting are listed in the Key Resources Table above. To facilitate reporter transgene insertion, we constructed a homology-directed DNA repair (HDR) template. 500 bp arms of homology (AOH; 5 0 and 3 0 ) were purchased (IDT); the 5 0 AOH contains sequences corresponding to all of Abcb1a exon 28 (204 bp) -minus the stop codon -plus the last 204 bp of intron 27-28; the 3 0 AOH contains the first 500 bp of the 3 0 untranslated region (UTR) downstream of the stop codon. Synonymous point mutations were introduced into both 5 0 and 3 0 AOH at the protospacer-adjacent motifs (PAMs) to remove Cas9-cleavase activity toward the HDR template. AOHs were then assembled into an ampicillin-resistant cloning vector (pSTBlue-1, Novagen) together with bicistronic reporter elements in the following order: 5 0 AOH (no Abcb1a stop codon) -glycine-serine-glycine (GSG) linker (in-frame, 5
0 -GGATCCCGA-3 0 ) -P2A peptide (in-frame) -ametrine open reading frame (in-frame, with stop codon) -3 0 AOH. Correct assembly was confirmed by sequencing, and the linear HDR template was excised from pSTBlue-1 via restriction digest (PmeI/NotI), and gel purified for use in zygote injections. Approximately 150 C57BL/6 zygotes were generated by in vitro fertilization (IVF), and micro-injected with: gRNAs (10 mg each), linearized HDR template (10 mg), and Cas9-cleavase mRNA (10 mg). 76 zygotes were gown to the 400-cell blastocyst stage and implanted into 8-week old female surrogate mothers; live pups were analyzed for transgene insertion using genotyping primers that anneal outside of the targeted region (see Key Resources Table above) . 19 live pups were recovered from the targeting; one female founder pup showed correct insertion of the full transgene by genotyping. Histology Colon (proximal, distal) or small intestine (proximal, mid, distal/ileum) sections ($1 cm) were cut from euthanized Rag1 À/À mice 6-to 8-weeks post-T cell transfer. In some experiments, 10 cm segments of distal small intestine and whole colon were dissected from mice and fixed intact. All tissues were fixed in 10% neutral buffered formalin, embedded into paraffin blocks, cut for slides, and stained with hematoxylin and eosin (H&E). H&E-stained sections were analyzed and scored blindly; colons as in (Wirtz et al., 2007) , and small intestines/ilea as in (Kosiewicz et al., 2001 ).
T Cell Transfer Colitis
Treating transferred Rag1
-/-mice with antibiotics Rag1 À/À mice receiving different donor T cell genotypes (i.e., wild-type versus Mdr1-deficient T cells; shCD8-versus shMdr1-expressing T cells) were separated upon initial onset of weight loss (typically 3-to 4-weeks post-T cell transfer) into cages that received water alone, or water containing antibiotics: ampicillin (1 M), vancomycin (0.5 M), metronidazole (1 M), neomycin (1 M), streptomycin (2 M). Bottles containing water with or without antibiotics were replaced twice weekly during assessment of weights.
Treating transferred Rag1 -/-mice with cholestyramine Cholestyramine (CME) was administered as a dietary supplement to transferred Rag1 À/À mice. Briefly, 1 kg of standard chow pellets (2920X Teklad irradiated global soy protein free extruded rodent diet, Envigo) were pulverized to a fine powder using a Professional Series 200 food processor (VitaMix), weighed, and supplemented with CME (2% w:w). An equal amount of ground powder food without CME was used as the control diet. One week prior to initiating treatment (typically 2-weeks post-T cell transfer), solid food was removed and replaced with control powder food (no CME) provided in covered feeding containers (Ancare Corporation). Upon onset of weight loss, transferred Rag1 À/À mice were separated into cages receiving powder food with or without CME. Each cage contained mixtures of Rag1 À/À mice receiving wild-type or Mdr1 null T cells. Covered feeding containers were exchanged, cleaned, and autoclaved weekly.
Bile acid measurements
Bile acid concentrations in feces (for CME treatment experiments) or small intestine luminal content (siLC) were quantified using the Total Bile Acids Assay Kit (Diazyme Laboratories) per manufacturer's instructions. For bile acid measurements in CME treatment experiments, bile acids were extracted with tert-Butanol as previously described (Bhat et al., 2003) .
Microbiome analyses
Genomic DNA from fecal stool of transferred Rag1 À/À mice was purified by QIAamp DNA Stool Mini Kit (QIAGEN) according to manufacturer's instructions. Total 16S rDNA was quantified by real-time PCR performed on a StepOnePlus real time PCR instrument (Life Technologies/Applied Biosystems), using Power SYBR green mastermix and universal 16S rDNA primers listed above in the Key Resources Table. Bacterial species were quantified by 16S ribosomal DNA sequencing using the Ion 16S Metagenomics kit (Life Technologies). Genomic DNA from cecal stool was amplified utilizing two primer sets that selectively amplify the hypervariable regions against 16S rRNA gene V2-4-8 and V3-6, 7-9, respectively. Amplicons for each sample were pooled and adaptor ligated with barcoded adaptors specific for Ion Torrent platforms. Samples were then pooled at equimolar ratios and sequenced using 400 bp chemistry on Ion Torrent Personal Genome Machine using 316 and 318 chips. Data was analyzed with Ion Reporter Software Ion 16S Metagenomics kit analysis module (Life Technologies).
Mononuclear cell isolation
Single-cell suspensions were prepared from spleen, peripheral lymph nodes, or mesenteric lymph nodes (MLN) by flushing through 70 mm nylon filters (BD Biosciences). For isolating cells from intestinal tissues, whole small intestines (duodenum to terminal ileum), small intestinal segments (proximal 1/3, middle 1/3, distal 1/3), or whole colons (cecum to anus) were removed, flushed with PBS to remove the fecal contents, and opened longitudinally; peyers patches were excised from small intestines. Tissues were cut into small ($3 cm) segments, and incubated for 30 min at room temperature in DMEM media without phenol red (Thermo Fisher Scientific) plus 0.15% DTT (Sigma-Aldrich) to remove mucus. After washing with media, intestines were incubated for 30 min at room temperature in media containing 1 mM EDTA (Amresco) to remove the epithelium. After washing again with media, lamina propria was digested in media containing 0.25 mg/mL liberase TL and 10 U/mL RNase-free DNaseI (both from Roche) in a bacterial incubator (Environ Shaker; Labline) for 15-25 min at 37 C. Single cell suspensions were passed through 70 mm nylon filters and mononuclear cells were isolated by 70/30% percoll gradient centrifugation (Sigma-Aldrich). Mononuclear cells were washed twice in complete T cell medium, counted, and resuspended for FACS analysis or sorting.
CD4
+ T cell isolation CD4 + CD25 -T cells were magnetically purified from spleen mononuclear cells using an EasySep T cell negative isolation kit (Stem Cell Technologies), Manufacturer's instructions were followed, except for the addition of a separate biotin anti-mouse CD25 antibody (0.5 mg/mL; eBioscience) along with the supplied antibody cocktail. Table above) for 20 min at room temperature. At completion, cells were washed once with PBS, resuspended in either PBS (for Rh123-labeled samples), or PBS plus 1% PFA, and acquired on LSRII or FACSCantoII cytometers (BD Biosciences). The Cellular Reactive Oxygen Species (ROS) Detection Assay Kit (Deep Red Fluorescence; Abcam) was used to assess ROS production. The ROS probe was added together with viability dyes and surface antibody cocktails in PBS, and incubated for 30 min at room temp. Stained cells were washed with PBS, fixed in PBS plus 4% PFA, and run immediately on the flow cytometer. For Rh123 labeling and efflux, whole mononuclear cells or purified T cells were labeled with complete medium containing 1 mg/mL Rh123 for 30 min on ice. Labeled cells were washed with cold media, resuspended in room temp media with or without elacridar (0.1 mM), and then placed in a 37 C tissue culture incubator for 30-60 min to permit Mdr1-dependent efflux. After efflux, cells were washed and stained with viability dyes and surface antibodies in ice-cold PBS for 20 min. After staining, cells were washed and resuspended in cold PBS, and acquired immediately on a cytometer. For Rh123 labeling and efflux experiments in the presence of mouse intestinal contents or synthetic bile acids, cells were kept in PBS (not media) throughout the protocol.
Intracellular FACS analysis
For intracellular stains including transcription factors (e.g., RORgt, Foxp3), cells were washed in PBS after surface staining, and then fixed and permeabilized using a Foxp3 intracellular staining kit (eBioscience) in accordance with manufacturer's instructions. For intracellular stains not including transcription factors (i.e., cytokines only), surface-stained cells were washed in PBS and fixed in PBS plus 4% PFA (15-20 min, room temp). After washing again in PBS, fixed cells were permeabilized in PBS plus 0.5% saponin and 1% FBS (10 min, room temp). Fluorochrome-conjugated anti-cytokine antibodies (see Key Resources Table above) were added directly to fixed cells and incubated at room temp for another 20 min. At completion, cells were washed once with PBS, resuspended in PBS plus 1% PFA, and acquired as above. All intracellular staining was performed after stimulating cells (4 hr) in media containing phorbol 12-myristate 13-acetate (PMA; 10 nM), ionomycin (1 mM), and brefeldin A (10 mg/mL) (all from Sigma-Aldrich).
FACS sorting
For cell sorting, stained cells were passed through 70 mm nylon filters, resuspended in DMEM media plus 2% serum, and sorted on a FACS AriaII machine (BD Biosciences). Sorted cells were collected in serum-coated tubes containing complete T cell media plus 50% serum. Gates used to sort Mdr1+/À T cells based on Rh123 efflux were set based on background Rh123 efflux in elacridar-treated cells.
FACS analysis
FACS data was analyzed using FlowJo software (TreeStar). Throughout, Mdr1 transport activity was quantified by dividing the mean fluorescence intensity (MFI) of Rh123 in elacridar-treated cells by that of cells incubated in media alone, or media containing mouse intestinal content or synthetic bile acids.
Naive CD4 + T cell differentiation
Magnetically-purified CD4 + CD25 -T cells from spleens of wild-type C57BL/6 (B6) mice were activated in sterile, tissue-culturetreated 96-well flat-bottom plates (Falcon). Wells were coated for 1-2 hr at 37 C with goat-anti-hamster whole IgG (0.3 mg/mL). After washing with PBS, T cells resuspended in media were added to coated wells along with hamster-anti-mouse CD3ε (0.3 mg/mL) and hamster-anti-mouse CD28 (0.5 mg/mL). For non-polarizing conditions (ThN), T cell activation was performed in media alone. For polarization into Th1, Th2, iTreg, or non-pathogenic or pathogenic Th17 cells, the following sets of neutralizing antibodies and recombinant cytokines (see Key Resources Table above) were added at the time of anti-CD3/anti-CD28 stimulation:
Th1 -20 ng/mL mouse IL-12 plus 0.5 mg/mL anti-mouse IL-4; Th2 -20 ng/mL mouse IL-4 plus 0.5 mg/mL anti-mouse IFNg; iTreg -1 ng/mL human TGFb1 plus 0.5 mg/mL anti-mouse IL-4 and 0.5 mg/mL anti-mouse IFNg; non-pathogenic Th17 -1 ng/mL human TGFb1 plus 10 ng/mL mouse IL-6, 0.5 mg/mL anti-mouse IL-4, 0.5 mg/mL anti-mouse IFNg and 1 mg/mL anti-mouse IL-2; pathogenic Th17 -1ng/mL human IL-1b plus 10 ng/mL mouse IL-6, 20ng/mL human IL-23, 0.5 mg/mL anti-mouse IL-4, 0.5 mg/mL anti-mouse IFNg and 1 mg/mL anti-mouse IL-2. Activated T cells were removed from antibody-coated wells after 48 hr (2 days), and expanded in uncoated wells until day 4 or 5. All cytokines and neutralizing antibodies were re-added at day 2 together with 10 IU/mL recombinant human IL-2 (for ThN, Th1, Th2, and iTreg conditions). No exogenous IL-2 was added to non-pathogenic or pathogenic Th17 cultures.
Induction of Mdr1 expression in CD4
+ T cells by antigen-presenting cells
+ effector/memory (Teff) cells from small intestinal lamina propria (siLP) were co-cultured in U-bottom 96-well plates with FACS-sorted antigen-presenting cell (APC) subsets from siLP or spleen at a 1:2 ratio and stimulated with soluble anti-CD3 (1 mg/ml). Mdr1 expression was analyzed on day 4 post-stimulation by Rh123 labeling and efflux, followed by staining with 7-AAD and anti-CD4.
Retroviral plasmids and transductions
All recombinant DNAs used in this study are listed in the Key Resources Table above . shRNAmirs against mouse CD8 (Cd8a) and Mdr1 (Abcb1a, Abcb1b) were purchased from TransOMIC Technologies. shRNAmirs were PCR amplified and cloned into GFPor ametrine-expressing murine retroviral vectors (LMPd) containing the enhanced miR-30 cassette (Fellmann et al., 2013) . HA-tagged human ABCB1 (hMDR1) was purchased from Addgene. Full-length ABCB1 was PCR-amplified without the HA-tag, and cloned into an ametrine-expressing LMPd vector without the miR-30 expression cassette. An empty LMPd.ametrine vector was generated by cutting out ABCB1 from the modified vector, blunting the restriction sites, and re-ligating. Transport-defective mutant MDR1 (DMDR1, Y401A/Y1044A; Kim et al., 2006) was generated using a QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). All retroviral constructs were confirmed by sequencing prior to use in cell culture experiments. Retroviral particles were produced in PLAT-E cells; harvested supernatants were filtered through a 45 mm filter (BD Biosciences), concentrated by centrifugation (6,000 x g; 18 hr; 4 C) and used to transduce NIH 3T3 fibroblasts or 24 hr-stimulated CD4 + CD25 -T cells.
Isolation of intestinal luminal contents
Feces from colons or small intestines were collected in 15 mL conical tubes, weighed, and diluted in media or PBS (2 parts media or PBS:1 part feces). Contents were mixed thoroughly by high-speed vortexing for 2 min, and feces was pelleted by centrifugation (1,000 x g; 10 min; room temperature). Supernatants were transferred to clean eppindorf tubes and cleared of debris by another round of high-speed centrifugation (13,000 x g; 20 min; room temperature). Supernatants were re-collected, sterile-filtered through 0.2 mm syringe filters (BD Biosciences), aliquoted, and stored at À80 C. Lumen content from small intestine (siLC) or colon (cLC) was added to Rh123-labeled splenocytes or purified CD4 + CD25 -T cells at dilutions ranging from 1%-16% (2-fold dilutions) of total culture volume (v:v) . Unless otherwise stated, results show T cells treated with 4% or 8% siLC or cLC. In some experiments, bile acids were depleted in siLC by pre-treatment with cholestyramine (CME). Here, siLC was treated for 1 hr with PBS, or PBS plus 50 mg/mL CME. CME-bound material was pelleted by centrifugation (1 min; 13,000 x g; room temperature), and supernatants were collected and used to treat Rh123-labeled T cells.
Bile acids
Synthetic bile acids: cholic acid (CA), glyco-cholic acid (gCA), tauro-cholic acid (tCA), deoxycholic acid (DCA), glyco-deoxycholic acid (gDCA), tauro-deoxycholic acid (tDCA), chenodeoxycholic acid (CDCA), glyco-chenodeoxycholic acid (gCDCA), or tauro-chenodeoxycholic acid (tCDCA) (all from Sigma-Aldrich) were reconstituted in PBS, aliquoted, and stored at 4 C.
Modulation of T cell cytokine expression by bile acids
Single cell suspensions of whole splenocytes from FVB wild-type or Mdr1 null (Abcb1a/1b À/À ) mice, or EL4 cells, were pre-treated with or without glycine-or taurine-conjugated CDCA in complete T cell media for 4 hr prior to PMA/ionomycin stimulation (4 hr; see Intracellular FACS analysis above) In some experiments, tCDCA (1.2 mM) was added alone, or together with elacridar (0.1 mM) for 4 hr prior to stimulation and staining.
Bile acid-induced cytotoxicity Single cell suspensions of whole splenocytes from FVB wild-type or Mdr1-deficient mice, B6 wild-type or Mdr1-reporter mice, or EL4 cells, were treated with or without tCDCA (1.2 mM) in the presence or absence of elacridar (0.1 mM) for 18-24 hr. In other experiments, splenocytes were treated for 8 hr with or without 1.2 mM tCDCA, 0.5 mM hydrogen peroxide (H 2 O 2 ), 15 mM menadione, or 50 mM 13-hydroperoxy-octadecadienoic acid (13-HpODE) +/À 125 mM N-acetyl-L-cysteine (N-Ac). mice, approximately 10,000 sorted cells were processed directly to generate cDNA using the Clontech SMART-Seq v4 Ultra Low Input Kit (Clontech). The generated cDNA was size selected using beads to enrich for fragments > 400 bp. The enriched cDNA was converted to Illumina-compatible libraries using the NEBNext Ultra II DNA kit (New England Biolabs) using 1ng input. All libraries used for sequencing were quantified using Qubit, and validated on Bioanalyzer DNA high sensitivity chips (Agilent) and qPCR (Kappa Biosystems). Barcoded libraries were pooled at equimolar ratios and sequenced using single-end 75 bp reads on a NextSeq 500 instrument (Illumina). Raw sequencing reads (fastq files) were mapped to the mm9 genome using TopHat (Trapnell et al., 2009 ). The number of reads falling into each gene defined by RefSeq gene annotations were quantified using HTSeq-count. DESeq software (Anders and Huber, 2010 ) was used to detect differentially expressed genes between samples. Normalized gene expression was analyzed using the GenePattern software suite (https://genepattern.broadinstitute.org/), and visualized using MultiPlot or Hierarchical Clutering Viewer modules; only annotated genes displaying normalized expression (RPKM) values R 1.5 are shown for each experiment. Pathway analysis of differentially expressed gene sets was performed using the DAVID Functional Annotation Tool (https://david.ncifcrf.gov/summary.jsp).
RNA sequencing
Nanostring
Cell pellets (10-30k cells/condition) were lysed in 5 mL RLT buffer containing fresh 2-mercaptoethanol (QIAGEN). Frozen lysates were sent to Nanostring Technologies (Seattle, WA) or the University of Miami Genomics Core Facility (Miami, FL) for analysis on nCounter platforms using custom codesets. Raw data were normalized and analyzed using nSolver software (Version 1.1; Nanostring Technologies). RNA counts were normalized using 3 housekeeping genes (Rps19, Gapdh, Actinb), with a cutoff for expression based on the highest negative control on the chip. Normalized RNA counts were exported to Microsoft Excel and presented using GraphPad Prism Software.
qPCR RNA was isolated from cultured or ex vivo-isolated cells using RNeasy columns with on-column DNase treatment (QIAGEN); this was used to synthesize cDNA via a high capacity cDNA reverse transcription kit (Life Technologies/Applied Biosystems). Taqman qPCR was performed on a StepOnePlus real time PCR instrument (Life Technologies/Applied Biosystems) using commercial taqman primer/probe sets for Abcb1a (Mm00607939_s1) and Gapdh (mm99999915_g1) from Life Technologies.
QUANTIFICATION AND STATISTICAL ANALYSES
Statistical analyses were performed using Prism (GraphPad). P values were determined by paired or unpaired Student's t tests, oneway ANOVA, and ROC analyses as appropriate. Statistical tests are indicated throughout the Figure legends. Differences were considered significant when p < 0.05 (* p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001), and levels of significance are specified throughout the Figure legends . Data are shown as mean values ± SEM throughout. For histological analyses, certified veterinary pathologists were 'blinded' to the allocation of animals and experimental groups.
